References
Dello Strologo L, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, de Sanctis L, Ponzone A, Gallucci M, Bisceglia L, Zelante L, Jimenez-Vidal M, Font M, Zorzano A, Rousaud F, Nunes V, Gasparini P, Palacín M, Rizzoni G (2002) Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13:2547–2553
Sany J, Combe B, Verdie-Petibon D, Tagemouati A, Daures JP (1990) Long-term tolerability of tiopronin (acadione) in the treatment of rheumatoid arthritis. Apropos of 140 personal cases. Rev Rhum Mal Osteoartic 57:105–111
Tasic V, Lozanovski VJ (2011) Nephrotic syndrome occurring during tiopronin treatment for cystinuria. Eur J Pediatr 170:247–249. https://doi.org/10.1007/s00431-010-1315-3
Reveillaud RJ, Blanc G, Daudon M (1978) Nephrotic syndrome and skin disorders appearing during alpha-mercapto-propionyl-glycine treatment of 2 cases of cystinic lithiasis. J Urol Nephrol 84:663–667
Zheng Z, Xue Y, Jia J, Wei L, Shang W, Lin S (2014) Tiopronin-induced membranous nephropathy: a case report. Ren Fail 36:1455–1460. https://doi.org/10.3109/0886022X.2014.926754
Rizzoni G, Pavanello L, Dussini N, Chiandetti L, Zacchello G (1979) Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine. J Urol 122:381–382
Salvarani G, Macchioni P, Rossi F, Iori I, Filippi G (1985) Nephrotic syndrome induced by tiopronin: associated with the HLA-DR3 antigen. Arthritis Rheum 28:595–596
Ferraccioli GF, Peri F, Nervetti A, Mercadanti M, Cavalieri F, Dall’Aglio PP, Savi M, Ferrari C (1986) Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics. Clin Exp Rheumatol 4:9–15
Zhong H, Wang L, Gu Z, Cui M, Liu X, Pang X (2019) Minimal change disease induced by tiopronin: a rare case report and a review of the literature. Ann Transl Med 7:398. https://doi.org/10.21037/atm.2019.07.42
Stratta P, Coratelli P, Camussi G, Passavanti G, Segoloni GP, Coppo R, Amerio A, Vercellone A (1978) Sindrome nefrosica durante trattamento con 2-mercaptopropionilglicina. Minerva Nefrol 25:87–92
Ambanelli U, Manganelli P, Ferraccioli GF (1982) Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients. Z Rheumatol 41:235–239
Author information
Authors and Affiliations
Contributions
All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-019-04439-9.
Rights and permissions
About this article
Cite this article
Aksoy, O.Y., Cakar, N. Nephrotic syndrome in a patient with cystinuria: Answers. Pediatr Nephrol 35, 979–980 (2020). https://doi.org/10.1007/s00467-019-04440-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04440-2